Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e06bbf2a93ce8414011cb5ba011faf8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03 |
filingDate |
2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8345e6a299bf92b47cc5c6788fb2b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59eee93f0e4785b586039ab71917ec4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e732f53d3e3858db5b488464119b0bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_469986c615d2015f28f01d04d430182b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09aea6c9603d45559aaebc32c87f622d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d23bb91bcc22a7a93c704f13ef0e982 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f24f69be5bef674ccf97c1d19dd29b64 |
publicationDate |
2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140045161-A |
titleOfInvention |
A composition for the treatment or prevention of inflammatory diseases, which comprises an algae maternal extract or a fraction thereof as an active ingredient |
abstract |
The present invention relates to a composition for the treatment or prevention of an inflammatory disease, and provides a pharmaceutical composition for preventing or treating an inflammatory disease containing an extract of Myagropsis myagroides or a fraction of the extract as an active ingredient. Solitary of the present invention more Sargassum extract or its fractions prior known Foucault xanthine (fucoxanthin) inhibiting to nitrogen monoxide (NO), prostaglandin E 2 (prostaglandin E 2, PGE 2) , and production of inflammatory cytokines, does not at all contain In addition, iNOS and COX-2 effectively inhibit expression, and thus can be effectively used for prevention and treatment of inflammatory diseases. |
priorityDate |
2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |